EPO Patents = 3

Trademarks = 8

Forward Citations = 84

Loading Chart...

16 inventors (with patents filed for the assignee):

Xiaolan Zhou (3 out of 25 patents)

Christopher Haqq (2 out of 4 patents)

Huiquan Han (2 out of 15 patents)

4. Jeonghoon Sun (2 out of 38 patents)

5. Lei-Ting Tony Tam (2 out of 12 patents)

6. Isaac Ciechanover (2 out of 2 patents)

7. John Zhao-Nian Lu (2 out of 2 patents)

8. Hq Han (1 out of 11 patents)

9. Mark Leo Michaels (1 out of 26 patents)

10. Hui-Quan Han (1 out of 14 patents)

11. Keith Soo-Nyung Kwak (1 out of 15 patents)

12. Thomas Charles Boone (1 out of 54 patents)

13. Rohini Deshpande (1 out of 6 patents)

14. Yue-Sheng Li (1 out of 31 patents)

15. John Lu (1 out of 2 patents)

5 patents: Sort by Forward Citations

1. 12383572 - Administration of an anti-activin-a compound to a subject (2025-08-12),

2. 11925663 - Methods of managing tumor flare in adoptive immunotherapy (2024-03-12),

3. 11541070 - Administration of an anti-activin-A compound to a subject (2023-01-03),

4. 8501678 - Variant activin receptor polypeptides and uses thereof (2013-08-06),

5. 8410043 - Stabilized activin IIB receptor polypeptides and uses thereof (2013-04-02),

Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company with a focus on developing novel treatments for cancer, autoimmune, and viral diseases. They leverage their deep understanding of T-cell biology to deliver potentially transformative therapies to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#21 in Brisbane, CA

#11,741 in California

#50,237 in US

Brisbane, CA, United States of America

Atara Biotherapeutics, Inc.